Avalanche Biotechnologies, Inc.
Avalanche Biotechnologies, Inc. (AAVL) is a publicly traded company in the Unknown sector. Across all available filings, 17 corporate insiders have executed 140 transactions totaling $86.3M, demonstrating a bullish sentiment with $24.7M in net insider flow. The most recent transaction on Feb 29, 2016 involved a transaction of 3,907 shares valued at $0.
AAVL Insider Activity Summary
Who Is Buying AAVL Stock?
No significant insider buying has been recorded for AAVL in the recent period.
Who Is Selling AAVL Stock?
No significant insider selling has been recorded for AAVL in the recent period.
Is Avalanche Biotechnologies, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for AAVL is bullish with an Insider Alignment Score of 64/100 and a net flow of $24.7M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
AAVL Frequently Asked Questions
Understanding AAVL Insider Activity
Insider trading at Avalanche Biotechnologies, Inc. (AAVL) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 17 insiders are actively trading AAVL stock, having executed 140 transactions in the past 90 days. The most active insider is Special Situations Fund, L.p. Deerfield (Executive), who has made 24 transactions totaling $31.9M.
Related Tools
Track Avalanche Biotechnologies, Inc. Insider Activity
Get notified when executives and directors at AAVL file new Form 4 transactions